Kalos M - Search Results

1

Chimeric antigen receptor-modified T cells for acute lymphoid leukemia.

Grupp SA, Kalos M, Barrett D, Aplenc R, Porter DL, Rheingold SR, Teachey DT, Chew A, Hauck B, Wright JF, Milone MC, Levine BL, June CH. Grupp SA, et al. Among authors: kalos m. N Engl J Med. 2013 Apr 18;368(16):1509-1518. doi: 10.1056/NEJMoa1215134. Epub 2013 Mar 25. N Engl J Med. 2013. PMID: 23527958 Free PMC article.

2

Improved anti-leukemia activities of adoptively transferred T cells expressing bispecific T-cell engager in mice.

Liu X, Barrett DM, Jiang S, Fang C, Kalos M, Grupp SA, June CH, Zhao Y. Liu X, et al. Among authors: kalos m. Blood Cancer J. 2016 Jun 3;6(6):e430. doi: 10.1038/bcj.2016.38. Blood Cancer J. 2016. PMID: 27258611 Free PMC article.

3

Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cells.

Gill S, Tasian SK, Ruella M, Shestova O, Li Y, Porter DL, Carroll M, Danet-Desnoyers G, Scholler J, Grupp SA, June CH, Kalos M. Gill S, et al. Among authors: kalos m. Blood. 2014 Apr 10;123(15):2343-54. doi: 10.1182/blood-2013-09-529537. Epub 2014 Mar 4. Blood. 2014. PMID: 24596416 Free PMC article.

4

T cells expressing chimeric antigen receptors can cause anaphylaxis in humans.

Maus MV, Haas AR, Beatty GL, Albelda SM, Levine BL, Liu X, Zhao Y, Kalos M, June CH. Maus MV, et al. Among authors: kalos m. Cancer Immunol Res. 2013 Jul;1(1):26-31. doi: 10.1158/2326-6066.CIR-13-0006. Epub 2013 Apr 7. Cancer Immunol Res. 2013. PMID: 24777247 Free PMC article. Clinical Trial.

5

Mesothelin-specific chimeric antigen receptor mRNA-engineered T cells induce anti-tumor activity in solid malignancies.

Beatty GL, Haas AR, Maus MV, Torigian DA, Soulen MC, Plesa G, Chew A, Zhao Y, Levine BL, Albelda SM, Kalos M, June CH. Beatty GL, et al. Among authors: kalos m. Cancer Immunol Res. 2014 Feb;2(2):112-20. doi: 10.1158/2326-6066.CIR-13-0170. Cancer Immunol Res. 2014. PMID: 24579088 Free PMC article. Clinical Trial.

6

Chimeric Antigen Receptor Therapy for B-cell Malignancies.

Porter DL, Kalos M, Zheng Z, Levine B, June C. Porter DL, et al. Among authors: kalos m. J Cancer. 2011;2:331-2. doi: 10.7150/jca.2.331. Epub 2011 Jun 1. J Cancer. 2011. PMID: 21716851 Free PMC article.

7

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia.

Porter DL, Levine BL, Kalos M, Bagg A, June CH. Porter DL, et al. Among authors: kalos m. N Engl J Med. 2011 Aug 25;365(8):725-33. doi: 10.1056/NEJMoa1103849. Epub 2011 Aug 10. N Engl J Med. 2011. PMID: 21830940 Free PMC article. Clinical Trial.

8

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia.

Kalos M, Levine BL, Porter DL, Katz S, Grupp SA, Bagg A, June CH. Kalos M, et al. Sci Transl Med. 2011 Aug 10;3(95):95ra73. doi: 10.1126/scitranslmed.3002842. Sci Transl Med. 2011. PMID: 21832238 Free PMC article. Clinical Trial.

9

Treatment of advanced leukemia in mice with mRNA engineered T cells.

Barrett DM, Zhao Y, Liu X, Jiang S, Carpenito C, Kalos M, Carroll RG, June CH, Grupp SA. Barrett DM, et al. Among authors: kalos m. Hum Gene Ther. 2011 Dec;22(12):1575-86. doi: 10.1089/hum.2011.070. Epub 2011 Sep 23. Hum Gene Ther. 2011. PMID: 21838572 Free PMC article.

10

Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biology.

Kalos M, June CH. Kalos M, et al. Immunity. 2013 Jul 25;39(1):49-60. doi: 10.1016/j.immuni.2013.07.002. Immunity. 2013. PMID: 23890063 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

118 results

Search Page